期刊
HUMAN MOLECULAR GENETICS
卷 26, 期 R2, 页码 R128-R138出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddx240
关键词
-
资金
- BBSRC [BB/N01992X/1, BB/N001664/1]
- Wellcome Trust [106174/Z/14/Z]
- Said Foundation
- Circadian Therapeutics
- BBSRC [BB/N01992X/1, BB/N001664/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/N01992X/1, BB/N001664/1] Funding Source: researchfish
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/L001179/1] Funding Source: researchfish
Circadian rhythms are 24-h rhythms in physiology and behaviour generated by molecular clocks, which serve to coordinate internal time with the external world. The circadian system is a master regulator of nearly all physiology and its disruption has major consequences on health. Sleep and circadian rhythm disruption (SCRD) is a ubiquitous feature in today's 24/7 society, and studies on shift-workers have shown that SCRD can lead not only to cognitive impairment, but also metabolic syndrome and psychiatric illness including depression (1,2). Mouse models of clock mutants recapitulate these deficits, implicating mechanistic and causal links between SCRD and disease pathophysiology (3-5). Importantly, treating clock disruption reverses and attenuates these adverse health states in animal models (6,7), thus establishing the circadian system as a novel therapeutic target. Significantly, circadian and clock-controlled gene mutations have recently been identified by Genome-Wide Association Studies (GWAS) in the aetiology of sleep, mental health and metabolic disorders. This review will focus upon the genetics of circadian rhythms in sleep and health.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据